{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:49:48Z","timestamp":1791614988985,"version":"4.3.4"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Type IV collagen\u2013related nephropathies comprise a spectrum of inherited glomerular disorders, with Alport disease representing the most severe phenotype. In children, these conditions often present with isolated hematuria, while progressive kidney disease typically develops later. Early diagnosis may therefore enable timely family-based risk assessment and preventive nephrological care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed data about\u00a018 children with persistent microscopic and\/or macroscopic hematuria who underwent targeted next-generation sequencing of COL4A3, COL4A4, and COL4A5, with variant classification according to ACMG criteria. Clinical data and family history were reviewed, and cascade testing of relatives was performed when feasible.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Pathogenic COL4A5 variants were identified in 12 patients (67%) and likely pathogenic COL4A5 variants in two additional patients. Pathogenic variants in COL4A4 and COL4A3 were detected in one patient each, while two patients harbored only COL4A3 variants of uncertain significance. Glycine-substituting missense variants were the most frequent molecular defect (9\/18 cases), whereas loss-of-function variants were identified in 7\/18 patients, including variants in COL4A5, COL4A3 and COL4A4. Proteinuria was present in 44% of patients, while kidney function was preserved at diagnosis. A positive family history of kidney disease or hematuria was present in 61% of families, and kidney failure in adult relatives in 28%. Cascade testing identified additional genetically affected relatives in all tested families.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Hematuria in pediatric age\u00a0may represent an early manifestation of COL4A-related nephropathies and should prompt genetic evaluation. Molecular diagnosis in childhood facilitates identification of affected relatives and supports early surveillance and family-based preventive strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/joneph\/aajag086","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T11:41:55Z","timestamp":1775648515000},"page":"1188-1195","source":"Crossref","is-referenced-by-count":0,"title":["Pediatric hematuria as a gateway to family genetic investigation in type IV collagen nephropathies: experience from a regional cohort"],"prefix":"10.1093","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5217-1766","authenticated-orcid":false,"given":"John","family":"Dotis","sequence":"first","affiliation":[{"name":"Third Department of Pediatrics, Aristotle University of Thessaloniki, Hippokration General Hospital of Thessaloniki , Thessaloniki ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Kondou","sequence":"additional","affiliation":[{"name":"First Department of Pediatrics, Aristotle University of Thessaloniki, Hippokration General Hospital of Thessaloniki , Thessaloniki ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athina","family":"Ververi","sequence":"additional","affiliation":[{"name":"Centre of Genetics for Rare Diseases, Papageorgiou Hospital , Thessaloniki ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Karava","sequence":"additional","affiliation":[{"name":"First Department of Pediatrics, \u201cAghia Sophia\u201d Children's Hospital, National and Kapodistrian University of Athens , Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fotios","family":"Papachristou","sequence":"additional","affiliation":[{"name":"First Department of Pediatrics, Aristotle University of Thessaloniki, Hippokration General Hospital of Thessaloniki , Thessaloniki ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantinos","family":"Deltas","sequence":"additional","affiliation":[{"name":"Center of Excellence in Biobanking and Biomedical Research, University of Cyprus , Nicosia ,","place":["Cyprus"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikoleta","family":"Printza","sequence":"additional","affiliation":[{"name":"First Department of Pediatrics, Aristotle University of Thessaloniki, Hippokration General Hospital of Thessaloniki , Thessaloniki ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"2026101002215803400_aajag086-B1","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/MNH.0000000000000983","article-title":"Alport syndrome and Alport kidney diseases - elucidating the disease spectrum","volume":"33","author":"Puapatanakul","year":"2024","journal-title":"Curr Opin Nephrol Hypertens."},{"key":"2026101002215803400_aajag086-B2","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1093\/ndt\/gfab334","article-title":"Heterozygous COL4A3\/COL4A4 mutations: the hidden part of the iceberg?","volume":"37","author":"Mastrangelo","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"2026101002215803400_aajag086-B3","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00467-022-05627-w","article-title":"Variants in genes coding for collagen type IV \u03b1-chains are frequent causes of persistent, isolated hematuria during childhood","volume":"38","author":"Alge","year":"2023","journal-title":"Pediatr Nephrol"},{"key":"2026101002215803400_aajag086-B4","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s00467-024-06538-8","article-title":"Detection of Alport gene variants in children and young people with persistent haematuria","volume":"40","author":"Ng","year":"2025","journal-title":"Pediatr Nephrol"},{"key":"2026101002215803400_aajag086-B5","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/ndt\/gfae265","article-title":"Diagnosis, management and treatment of the Alport syndrome - 2024 guideline on behalf of ERKNet, ERA and ESPN","volume":"40","author":"Torra","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"2026101002215803400_aajag086-B6","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med."},{"key":"2026101002215803400_aajag086-B7","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1007\/s00467-025-06683-8","article-title":"A 15-year experience highlighting the spectrum of Alport kidney disease in the pediatric population and novel genetic variants in COL4A3-5","volume":"40","author":"Andreja\u0161i\u010d","year":"2025","journal-title":"Pediatr Nephrol"},{"key":"2026101002215803400_aajag086-B8","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.3390\/genes15081016","article-title":"Alport syndrome: clinical utility of early genetic diagnosis in children","volume":"15","author":"Christodoulaki","year":"2024","journal-title":"Genes (Basel)."},{"key":"2026101002215803400_aajag086-B9","doi-asserted-by":"publisher","first-page":"764","DOI":"10.3390\/genes14030764","article-title":"Next-generation sequencing (NGS) analysis illustrates the phenotypic variability of collagen type IV nephropathies","volume":"14","author":"Zacchia","year":"2023","journal-title":"Genes (Basel)."},{"key":"2026101002215803400_aajag086-B10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12920-024-01953-0","article-title":"Four novel mutations identified in the COL4A3, COL4A4 and COL4A5 genes in 10 families with Alport syndrome","volume":"17","author":"Wang","year":"2024","journal-title":"BMC Med Genomics."},{"key":"2026101002215803400_aajag086-B11","doi-asserted-by":"publisher","first-page":"7691","DOI":"10.1038\/s41598-025-92520-9","article-title":"Pathogenic variants in the Alport genes are prevalent in the Singapore multiethnic population with highest frequency in the Chinese","volume":"15","author":"Lim","year":"2025","journal-title":"Sci Rep."},{"key":"2026101002215803400_aajag086-B12","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.3390\/genes13122203","article-title":"Novel and founder pathogenic variants in X-linked Alport syndrome families in Greece","volume":"13","author":"Hadjipanagi","year":"2022","journal-title":"Genes (Basel)."},{"key":"2026101002215803400_aajag086-B13","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1681\/ASN.0000000647","article-title":"Genotype-based molecular mechanisms in Alport syndrome","volume":"36","author":"Caparali","year":"2025","journal-title":"J Am Soc Nephrol."},{"key":"2026101002215803400_aajag086-B14","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1053\/j.akdh.2024.02.004","article-title":"Alport syndrome","volume":"31","author":"Chavez","year":"2024","journal-title":"Adv Kidney Dis Health."},{"key":"2026101002215803400_aajag086-B15","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfaf272","article-title":"Age at disease onset and risk of chronic kidney disease in patients with heterozygous disease-causing variants in COL4A3 and COL4A4","volume":"18","author":"Hu","year":"2025","journal-title":"Clin Kidney J."},{"key":"2026101002215803400_aajag086-B16","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.70053","article-title":"Effects of a novel COL4A3 homozygous\/heterozygous splicing mutation on the mild phenotype in a family with autosomal recessive Alport syndrome and a literature review","volume":"13","author":"Chen","year":"2025","journal-title":"Mol Genet Genomic Med."},{"key":"2026101002215803400_aajag086-B17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.matbio.2025.08.004","article-title":"Basement membrane structure and function: relating biology to mechanics","volume":"141","author":"Page-McCaw","year":"2025","journal-title":"Matrix Biol."},{"key":"2026101002215803400_aajag086-B18","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1038\/s41598-022-06525-9","article-title":"Genotype-phenotype correlations for COL4A3-COL4A5 variants resulting in Gly substitutions in Alport syndrome","volume":"12","author":"Gibson","year":"2022","journal-title":"Sci Rep."},{"key":"2026101002215803400_aajag086-B19","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3390\/genes15050593","article-title":"Genotype-phenotype correlations in Alport syndrome-A single-center experience","volume":"15","author":"Lujinschi","year":"2024","journal-title":"Genes (Basel)."},{"key":"2026101002215803400_aajag086-B20","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.kint.2020.10.040","article-title":"Mild X-linked Alport syndrome due to the COL4A5 G624D variant originating in the Middle Ages is predominant in Central\/East Europe and causes kidney failure in midlife","volume":"99","author":"\u017burowska","year":"2021","journal-title":"Kidney Int."},{"key":"2026101002215803400_aajag086-B21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2215\/CJN.04230321","article-title":"Guidelines for genetic testing and management of Alport syndrome","volume":"17","author":"Savige","year":"2022","journal-title":"Clin J Am Soc Nephrol."},{"key":"2026101002215803400_aajag086-B22","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00467-020-04819-6","article-title":"Clinical practice recommendations for the diagnosis and management of Alport syndrome in children, adolescents, and young adults-an update for 2020","volume":"36","author":"Kashtan","year":"2021","journal-title":"Pediatr Nephrol"},{"key":"2026101002215803400_aajag086-B23","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s12864-025-11466-4","article-title":"Whole exome sequencing shows novel COL4A3 and COL4A4 variants as causes of Alport syndrome in Rio Grande do Norte, Brazil","volume":"26","author":"de Ara\u00fajo","year":"2025","journal-title":"BMC Genom"},{"key":"2026101002215803400_aajag086-B24","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.3390\/biomedicines1206115","article-title":"Exploration of gene therapy for Alport syndrome","volume":"12","author":"Zhao","year":"2024","journal-title":"Biomedicines"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/joneph\/article-pdf\/39\/6\/1188\/70486956\/aajag086.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/joneph\/article-pdf\/39\/6\/1188\/70486956\/aajag086.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:22:04Z","timestamp":1791613324000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/39\/6\/1188\/8751491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":24,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,8,5]]},"published-print":{"date-parts":[[2026,10,10]]}},"URL":"https:\/\/doi.org\/10.1093\/joneph\/aajag086","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,7]]}}}